Results 261 to 270 of about 283,934 (290)

Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Smart and Multifunctional Materials Based on Electroactive Poly(vinylidene fluoride): Recent Advances and Opportunities in Sensors, Actuators, Energy, Environmental, and Biomedical Applications

Chemical Reviews, 2023
Carlos M Costa, Vanessa F Cardoso, Pedro Martins   +2 more
exaly  

Poly(ADP-ribose) polymerase inhibition: past, present and future

Nature Reviews Drug Discovery, 2020
Nicola J Curtin, Csaba Szabo
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Marsela Braunstein, Amit M Oza, Stephanie Lheureux   +2 more
exaly  

Poly(A) Tails ☆

2013
openaire   +1 more source

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Poly(A) Tail

2001
openaire   +1 more source

Poly(A) Tails and Spermatogenesis

Science, 2002
openaire   +1 more source

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

NAD+ metabolism and its roles in cellular processes during ageing

Nature Reviews Molecular Cell Biology, 2020
Anthony J Covarrubias, Rosalba Perrone, Alessia Grozio   +2 more
exaly